Exploring the Dark Side of Popular Weight Loss Medications and Their Potential Link to Suicidal Ideation
Recent reports have raised concerns about the potential link between popular weight loss drugs and suicidal thoughts. This article delves into the issue, shedding light on the possible risks associated with these medications and the ongoing investigations by health regulators.
HCN Medical Memo
As physicians. it’s crucial to be aware of these potential risks when prescribing weight loss medications. Patient safety should always be our top priority. Regular monitoring for symptoms of depression and suicidal ideation is recommended when prescribing these drugs.
- Dr. Anna Costakis states that suicidal ideation is often associated with depression, and some medications can trigger a depressed mood and even suicidal thoughts.
- The European Medicines Agency is reviewing 150 reports of self-injury and suicidal thoughts among people who’ve taken Ozempic or Wegovy, drugs in the class called GLP-1 receptor agonists.
- In the US, the FDA requires that weight management medications that work on the central nervous system carry a warning about suicidal thoughts.
According to the World Health Organization, close to 800,000 people die due to suicide every year, which is one person every 40 seconds.
- Neither Ozempic nor Wegovy carry warnings about suicidal ideation in Europe or the UK, as clinical trials have not shown evidence of an increased risk.
- Some patients believe that Ozempic, which is only FDA-approved to treat diabetes, should come with a warning.
More on Obesity/Weight Management